Mutations in the Fms-like tyrosine kinase 3 (FLT3) are the most frequent genetic abnormalities in AML, accounting for approximately 30% of cases, most commonly occurring as FLT3 internal tandem duplication (FLT3-ITD). Here, FLT3 is linked to acute myeloid leukemia.